BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 21, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Jan. 13, 2016
View Archived Issues
J.P. Morgan Healthcare Conference 2016: Medtronic to return $5 billion of freed cash to shareholders
SAN FRANCISCO — As Medtronic plc (Dublin) approaches the anniversary of its blockbuster Covidien deal, which closed a year ago this month, the company is making strides to prove the $42.9 billion acquisition is paying off.
Read More
J.P. Morgan Healthcare Conference 2016: Heartware suffers more heartache over MVAD, trial in limbo after thrombus events
Read More
Inside the Beltway: Califf breezes through Senate hearing for top job at the FDA
Read More
Company accused of lowering evidence bar: PDAC once again votes to recommend Probuphine implant
Read More
Silimed issues still not resolved: Sientra's new CEO updates physicians over crisis with Brazilian operations
Read More
Daily M&A: Smith & Nephew acquires BST-Cargel assets from Piramal Healthcare
Read More
Financings: Accuray closes $70M straight debt agreements with Cerberus
Read More
Patent Watch: Entac gets patent for technology to predict gastrointestinal impairment
Read More
World in Review: Polaris using DNAnexus for clinical omics
Read More
People in Places
Read More
product briefs
Read More
MDD's Oncology Extra
Read More
